Controlled curcumin release from nanofibers based on amphiphilic-block segmented polyurethanes.

Int J Pharm

Department of Chemical & Materials Engineering, New Mexico State University, MSC 3805, P.O. Box: 30001, Las Cruces, NM 88003-3805, USA.

Published: February 2020

A series of biodegradable amphiphilic-block segmented polyurethanes (SPUs) are designed and synthesized based on di-block and tri-block macrodiols of polycaprolactone (PCL) and polyethylene glycol (PEG). Curcumin, as a model herbal antibacterial agent, is used due to its effective inhibitory action against Gram-positive and Gram-negative bacteria. Curcumin-loaded nanofibers, with 400-900 nm diameter range, have been prepared by electrospinning of SPUs. The synthesized SPUs can be used for wound dressing applications due to their excellent mechanical properties and higher hydrophilicity in comparison to PCL-based polyurethane. The elongation-at-break of tri-block SPU with PEG-PCL-PEG soft segments is 350% when produced as an electrospun mat and that for film is 1500%. In vitro release of curcumin, examined by UV-Vis spectroscopy, shows a steady release during 18 days. The inclusion of PEG chains in the soft segment increases the hydrophilicity and biodegradation rate of the electrospun mats compared to a PCL-based polyurethane, which eventually results in a higher curcumin release rate. The antibacterial activity of 50 mg of 10% curcumin-loaded SPU nanofibers is about 100% and 93% against Escherichia coli (E. coli ATCC: 25922) and Staphylococcus aureus (S. aureus ATCC: 6538), respectively. Nontoxic behavior of the scaffolds is evaluated through MTT assay against L929 mouse fibroblast cells. The results show that the synthesized SPUs can be used as a nanoscale sustained release carrier. The SPU with PEG-PCL-PEG soft segments is an excellent candidate for wound dressing in tissues undergoing large deformations during normal activities.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2019.118947DOI Listing

Publication Analysis

Top Keywords

curcumin release
8
amphiphilic-block segmented
8
segmented polyurethanes
8
synthesized spus
8
wound dressing
8
pcl-based polyurethane
8
spu peg-pcl-peg
8
peg-pcl-peg soft
8
soft segments
8
release
5

Similar Publications

Protective effect of curcumin-loaded zeolitic imidazolate framework-8-based pH-responsive drug delivery system against Staphylococcus aureus infection.

Microb Pathog

January 2025

College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, Jiangsu Province, China; Animal Disease Prevention and Control Center of Ningxia Hui Autonomous Region, Yinchuan 750001, Ningxia, P. R. China. Electronic address:

Mastitis, generally caused by pathogenic microorganisms, is a serious disease in dairy farming. Staphylococcus aureus (S. aureus) is one of the main pathogens that induces mastitis in dairy cows.

View Article and Find Full Text PDF

The clinical application of curcumin (CUR) is restricted by its low solubility, instability, and poor bioavailability. To overcome these limitations, we developed a novel stearic acid-grafted inulin-based nano-delivery system for CUR encapsulation. The structure of stearoyl inulin (SA-IN) was characterized using Fourier-transform infrared spectroscopy, hydrogen nuclear magnetic resonance, thermogravimetric analysis, and contact angle measurements.

View Article and Find Full Text PDF

In recent years, the use of cationic peptides as alternative drugs with anticancer activity has received attention. In this study, the targeted release of curcumin (Cur) and CM11 peptide alone and together against hepatocellular carcinoma (HCC) was evaluated using chitosan nanoparticles (CS NPs) coated with Pres1 that target the SB3 antigen of HCC cells (PreS1-Cur-CM11-CS NPs). SB3 protein is the specific antigen of HCC and the PreS1 peptide is a part of the hepatitis B antigen, which can specifically bind to the SB3 protein.

View Article and Find Full Text PDF

Background/objectives: This study investigates for the first time the use of the prilling technique in combination with solvent evaporation to produce nano- and submicrometric PLGA particles to deliver properly an active pharmaceutical ingredient. Curcumin (CCM), a hydrophobic compound classified under BCS (Biopharmaceutics Classification System) class IV, was selected as the model drug.

Methods: Key process parameters, including polymer concentration, solvent type, nozzle size, and surfactant levels, were optimized to obtain stable particles with a narrow size distribution determined by DLS analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!